SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008343
Filing Date
2016-03-29
Accepted
2016-03-29 14:14:27
Documents
71
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 847377
2 ex21-1.htm EX-21.1 5697
3 ex23-1.htm EX-23.1 4854
4 ex31-1.htm EX-31.1 19614
5 ex31-2.htm EX-31.2 20711
6 ex32-1.htm EX-32.1 8798
7 ex32-2.htm EX-32.2 9027
  Complete submission text file 0001493152-16-008343.txt   4643583

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE prph-20151231.xml EX-101.INS 833052
9 XBRL SCHEMA FILE prph-20151231.xsd EX-101.SCH 48193
10 XBRL CALCULATION FILE prph-20151231_cal.xml EX-101.CAL 68170
11 XBRL DEFINITION FILE prph-20151231_def.xml EX-101.DEF 168479
12 XBRL LABEL FILE prph-20151231_lab.xml EX-101.LAB 371912
13 XBRL PRESENTATION FILE prph-20151231_pre.xml EX-101.PRE 273678
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 161534962
SIC: 2834 Pharmaceutical Preparations